Stephen A. Sherwin, president and chief executive officer of this biotechnology company, was named to the additional post of chairman.
Mr. Sherwin, 45 years old, succeeds A. Grant Heidrich III, 41, who remains a director.
Also, Daniel Hoth, 47, a senior vice president, was given the additional title of chief operating officer.
